Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma
Sponsor: Aura Biosciences
Summary
AU-011-403 is a multicenter long-term follow-up safety and efficacy study of subjects with early CM who previously participated in the AU-011-301 Phase 3 trial. There are no required interventions or use of AU-011 (bel-sar) in this long-term follow-up study
Official title: A Long-Term Follow-Up Study of Subjects Completing the AU-011-301 (CoMpass) Trial of Bel-sar for Early Choroidal Melanoma (Indeterminate Lesions/Small Choroidal Melanomas)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2026-03-27
Completion Date
2033-08-15
Last Updated
2026-08-19
Healthy Volunteers
No
Conditions
Interventions
Observational
The intention is to collect data for an additional \~5 years (Post AU-011-301 participation)
Locations (10)
Retinal Consultants Medical Group, Inc.
Sacramento, California, United States
W.K. Kellogg Eye Center - University of Michigan
Ann Arbor, Michigan, United States
Mayo Clinic
Rochester, Minnesota, United States
Retina Consultants of Oklahoma
Oklahoma City, Oklahoma, United States
Retina Consultants of Carolina
Greenville, South Carolina, United States
Tennessee Retina, PC
Nashville, Tennessee, United States
Austin Retina Associates Ophthalmology/Retina
Austin, Texas, United States
Retina Center of Texas
Southlake, Texas, United States
Retina Associates of Utah
Salt Lake City, Utah, United States
University of Wisconsin Madison
Madison, Wisconsin, United States